A heads up that I have an article due for publication in the December issue of “Pharmaceutical Manufacturing” updating how the Pharma industry has progressed in the last 5 years or so in terms of becoming more “lean.”
This is a sequel of sorts to the article I wrote some years ago on the same topic. Despite all the published case studies and conferences dedicated to this topic, the degree of progress (or lack thereof) is likely to be surprising to many. This article will show how this lack of progress is evidenced in the trend of pharma company inventory turns, and detail the root causes for the stagnation, and in some cases, regression.
I am in the progress of writing a follow-up article due for publication in the first quarter of 2018 that will detail an approach to address these root causes.
One other note of interest: in the course of writing this article I conducted some research on the progress of non-Pharma companies in terms of becoming more “lean.” The results were surprising.
Hope this is of interest.
Recent Comments